TABLE 2.
Outcome analysis.
Variable | Total | No factor group | Factor group | P-value |
Primary endpoint, n (%) | 89 (9.5) n = 939 |
24 (6.6) n = 363 |
65 (11.3) n = 576 |
0.017 |
Hepatic artery thrombosis, n (%) | 52 (5.5) n = 939 |
15 (4.1) n = 363 |
37 (6.4) n = 576 |
0.135 |
Portal vein thrombosis, n (%) | 30 (3.2) n = 939 |
6 (1.7) n = 363 |
24 (4.2) n = 576 |
0.033 |
Thrombosis of the inferior vena cava, n (%) | 16 (1.7) n = 939 |
4 (1.1) n = 363 |
12 (2.1) n = 576 |
0.258 |
30-day mortality, n (%) | 67 (7.1) n = 939 |
9 (2.5) n = 363 |
58 (10.1) n = 576 |
<0.001 |
Graft failure, n (%) | 108 (11.5) n = 939 |
20 (5.5) n = 363 |
88 (15.3) n = 576 |
<0.001 |
Pulmonary embolism, n (%) | 17 (1.8) n = 939 |
5 (1.4) n = 363 |
12 (2.1) n = 576 |
0.429 |
Myocardial infarction, n (%) | 20 (2.1) n = 939 |
6 (1.7) n = 363 |
14 (2.4) n = 576 |
0.422 |
Stroke, n (%) | 7 (0.7) n = 939 |
1 (0.3) n = 363 |
6 (1.0) n = 576 |
0.184 |
Deep vein thrombosis, n (%) | 5 (0.5) n = 939 |
1 (0.3) n = 363 |
4 (0.7) n = 576 |
0.390 |
Length of intensive care unit stay (d), mean ± SD | 9.6 ± 20.2 n = 934 |
5.9 ± 11.1 n = 361 |
12.0 ± 23.9 n = 573 |
<0.001 |
Length of hospital stay (d), mean ± SD | 48.7 ± 40.2 n = 939 |
38.9 ± 30.3 n = 363 |
55.0 ± 44.3 n = 576 |
<0.001 |
Intraoperative blood loss (ml), mean ± SD | 4370.9 ± 4490.7 n = 781 |
2793.6 ± 2559.4 n = 282 |
5262.3 ± 5068.0 n = 499 |
<0.001 |
Transfused RBC (TU), mean ± SD | 9.2 ± 11.3 n = 939 |
4.2 ± 5.4 n = 363 |
12.3 ± 12.8 n = 576 |
<0.001 |
Transfused PLT (TU), mean ± SD | 4.0 ± 5.0 n = 939 |
1.6 ± 2.3 n = 363 |
5.5 ± 5.7 n = 576 |
<0.001 |
Transfused FFP (TU), mean ± SD | 20.22 ± 17.25 n = 939 |
13.62 ± 10.96 n = 363 |
24.37 ± 19.11 n = 576 |
<0.001 |
Data are presented as absolute number (percentage) or mean ± SD. P-values refer to the comparison between no factor and factor group. Categorial data were compared using the chi-square test. Continuous data were compared using the Mann-Whitney U-test. Bold face indicates p-values < 0.05. SD, standard deviation; RBC, Red blood cells; PLT, Platelet concentrates; FFP, Fresh frozen plasma; TU, Transfusion units.